Literature DB >> 10685611

Kinetics of Na+, K+-ATPase inhibition by an endogenous modulator (II-A).

A Reinés1, C Peña, G Rodríguez de Lores Arnaiz.   

Abstract

We have previously reported the isolation by gel filtration and anionic exchange HPLC of two brain Na+, K+-ATPase inhibitors, II-A and II-E, and kinetics of enzyme interaction with the latter. In the present study we evaluated the kinetics of synaptosomal membrane Na+, K+-ATPase with II-A and found that inhibitory activity was independent of ATP (2-8 mM), Na+ (3.1-100 mM), or K+ (2.5-40 mM) concentration. Hanes-Woolf plots showed that II-A decreases Vmax in all cases; KM value decreased for ATP but remained unaltered for Na+ and K+, indicating respectively uncompetitive and noncompetitive interaction. However, II-A became a stimulator at 0.3 mM K+ concentration. It is postulated that brain endogenous factor II-A may behave as a sodium pump modulator at the synaptic region, an action which depends on K+ concentration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685611     DOI: 10.1023/a:1007599718356

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 2.  Role of endogenous brain "ouabain" in the sympathoexcitatory and pressor effects of sodium.

Authors:  J W Van Huysse; F H Leenen
Journal:  Clin Exp Hypertens       Date:  1998 Jul-Aug       Impact factor: 1.749

Review 3.  Ouabain-like factor.

Authors:  A Goto; K Yamada
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-03       Impact factor: 2.894

4.  Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.

Authors:  O V Fedorova; A Y Bagrov
Journal:  Am J Hypertens       Date:  1997-08       Impact factor: 2.689

5.  Differential properties between an endogenous brain Na+, K(+)-ATPase inhibitor and ouabain.

Authors:  C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

6.  Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.

Authors:  D M Tal; M D Yanuck; G van Hall; S J Karlish
Journal:  Biochim Biophys Acta       Date:  1989-10-02

7.  Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.

Authors:  A Y Bagrov; O V Fedorova; R I Dmitrieva; W N Howald; A P Hunter; E A Kuznetsova; V M Shpen
Journal:  Hypertension       Date:  1998-05       Impact factor: 10.190

8.  Differential effect of potassium on the action of digoxin and digoxigenin in guinea-pig heart.

Authors:  T Akera; S A Wiest; T M Brody
Journal:  Eur J Pharmacol       Date:  1979-08-15       Impact factor: 4.432

9.  The association with receptors regulates the Na+,K(+)-ATPase inhibitory potency of some cardioactive steroids.

Authors:  F Ebner; J Mermi
Journal:  Eur J Pharmacol       Date:  1991-05-25       Impact factor: 4.432

10.  An endogenous factor which interacts with synaptosomal membrane Na+, K(+)-ATPase activation by K+.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.